Hamps Bio Limited Auditor Reports

To,

The Board of Directors,

M/s. HAMPS BIO LIMITED

2900/112, G.I.D.C.,

Near Atul Limited, Bharuch,

Ankleshwar, Gujarat, India- 393002

Dear Sir,

Reference: - Proposed Public Issue of Equity Shares of Hamps Bio Limited

We have examined the attached Restated Financial Information of Hamps Bio Limited (herein referred to "the Company" or "the Issuer"), comprising the Restated Statement of Assets and Liabilities as at March 31,2024, March 31, 2023 and March 31, 2022, the Restated Statement of Profit and Loss, the Restated Cash Flow Statement for the period ended on March 31,2024, March 31, 2023 and March 31, 2022, the Restated Statement of Significant Accounting Policies, the Notes and Annexures as forming part of these Restated Financial Statements (collectively, the " Restated Financial Information"), as approved by the Board of Directors of the Company in their meeting held on 04^th June,2024 for the purpose of inclusion in the Draft Red Herring Prospectus/Red Herring Prospectus/Prospectus ("Offer Document") in connection with its proposed SME Initial Public Offer of equity shares ("SME IPO") prepared in terms of the requirements of:

a) Section 26 of Part I of Chapter III of the Companies Act, 2013 as amended(the "Act");

b) The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended ("SEBI ICDR Regulations");

c) The Guidance Note on Reports in Company Prospectuses (Revised 2020) issued by the Institute of Chartered Accountants of India ("ICAI"), as amended from time to time (the "Guidance Note").

a) The terms of reference and terms of our engagement agreed upon with you in accordance with our engagement letter dated 02^nd July, 2024 in connection with the proposed IPO of the Company;

b) The Guidance Note on Reports in Company Prospectus (Revised 2020) issued by the ICAI. The Guidance Note also requires that we comply with the ethical requirements of the Code of Ethics issued by the ICAI;

c) Concepts of test checks and materiality to obtain reasonable assurance based on verification of evidence supporting the Restated Financial Statements; and

d) The requirements of Section 26 of the Act and the ICDR Regulations.

a) Audited Financial Statements of the Company as at and for the period/year ended on March 31, 2024, March 31, 2023 and March 31, 2022 prepared in accordance with the Accounting Standards as prescribed under Section 133 of the Act, read with Rule 7 of the

a. Audit for the financial period ended on March 31, 2024, March 31, 2023 and March 31,

a) The "Restated Statement of Assets and Liabilities" as set out in Annexure I to this report, of the company, as at March 31,2024, and as at financial year ended on March 31, 2023 and for the period ended March 31, 2022 is prepared by the company and approved by the Board of Directors. These restated Statement of Assets and Liabilities, have been arrived at after making adjustments and regroupings to the individual financial statements of the company, as in our opinion were appropriate and more fully described in Significant Accounting Policies and Notes to Accounts as set out in Annexure XXXVII to this report.

b) The "Restated Statement of Profits & Loss" as set out in Annexure II to this report, of the Company for the financial period/year ended on March 31, 2024, March 31, 2023 and March, 2022 is prepared by the company and approved by the Board of Directors. These restated Statement of Profit & Loss have been arrived at after making adjustments and regroupings to the individual financial statements of the company, as in our opinion were appropriate and more fully described in Significant Accounting Policies and Notes to Accounts as set out in Annexure XXXVII to this report.

c) The "Restated Statement of Cash Flow" as set out in Annexure III to this report, of the Company for the Financial period/year ended on March 31, 2024, March 31, 2023 and March, 2022 is prepared by the company and approved by the Board of Directors. These restated Statement of Cash Flow, as restated have been arrived at after making adjustments and regroupings to the individual financial statements of the company, as in our opinion were appropriate and more fully described in Significant Accounting

a) have been made after incorporating adjustments for the changes in accounting policies, material errors and regrouping/reclassifications retrospectively in the respective financial year to which they relate; b) do not require any adjustment for modification as there is no modification in the underlying audit reports; c) have no extra-ordinary items that need to be disclosed separately in the accounts and requiring adjustments; d) have been prepared in accordance with the Act, ICDR Regulations and Guidance Note. e) do not require any adjustment for change in accounting policies as there was no change in the accounting policies. f) have no revaluation reserves which need to be disclosed separately.

We have also examined the following financial information as set out in annexure prepare by the management and as approved by the Board of Directors of the Company for the year ended on March 31, 2024, for the period ended on March 31, 2023, and March 31, 2022

Our report is intended solely for use of the management and for inclusion in the Offer Document in connection with the Proposed SME IPO of Equity Shares of the Company and our report should not be used, referred to or distributed for any other purpose without our prior consent in writing.